Longevity
Factlen Deep Dive
Drug Blocks Aging Protein to Regenerate Lost Cartilage in Mice and Human Samples, Offering Functional Cure for Osteoarthritis
7 sources · 22d ago
Factlen Research
EC Approves First Gene Replacement Therapy for Adults and Older Children with Spinal Muscular Atrophy
4 sources · 22d ago
Factlen Deep Dive
First Patient Dosed in Landmark Trial of Systemic Cellular Reprogramming Therapy
5 sources · 22d ago
More in Longevity
Factlen ResearchMetabolic Health
The Evidence Pack: How the First Once-Weekly Insulin is Rewriting Type 2 Diabetes Management
Endocrinologists & Clinicians 40%Drug Safety Regulators 35%Pharmaceutical Developers 25%
3 sources · 25d ago
Factlen Deep DiveLongevity Medicine
Major Human Trial Launches to Test Three FDA-Approved Drugs for Healthspan and New Regulatory Endpoint
Geroscience Researchers 40%Regulatory Pragmatists 35%Clinical Skeptics 25%
5 sources · 26d ago
Factlen ResearchNetwork Medicine
The Evidence Pack: How a Common Nasal Spray Emerged as a Computational Anti-Aging Candidate
Network Medicine Researchers 40%Clinical Pharmacologists 40%Geroscience Advocates 20%
4 sources · 27d ago
Factlen ExplainerSmoking Cessation
FDA Nears Approval of Cytisinicline, the First New Non-Nicotine Smoking Cessation Pill in Two Decades
Addiction Medicine Specialists 40%Public Health Advocates 35%Pharmacological Researchers 25%
6 sources · 27d ago
Factlen ResearchHealthspan Metrics
The Evidence Pack: How Recent US Life Expectancy Gains Are Translating Entirely Into Healthy Years
Biogerontologists 40%Public Health Economists 30%Health Equity Advocates 30%
3 sources · 27d ago
Factlen ExplainerObesity Medicine
FDA Approves CagriSema, the First Combination GLP-1 and Amylin Therapy for Weight Loss
Clinical Endocrinologists 40%Metabolic Researchers 35%Health Economists 25%
4 sources · 28d ago
Factlen ResearchLongevity Science
The Evidence Pack: How GLP-1 Receptor Agonists Reduce Biological Age on Epigenetic Clocks
Longevity Medicine Advocates 40%Clinical Skeptics 35%Trial Investigators 25%
4 sources · 28d ago
Factlen ExplainerPeptide Therapy
The Evidence Pack: How the Anti-Aging Peptide Epitalon Works as it Clears a Major FDA Hurdle
Longevity Researchers 40%Regulatory Agencies 35%Endocrinologists 25%
6 sources · 29d ago
Factlen Deep DiveGeroscience
The Evidence Pack: How Three FDA-Approved Drugs Are Being Tested to Slow Human Aging
Geroscience Researchers 45%Clinical Skeptics 35%Public Health Advocates 20%
6 sources · 29d ago
Factlen Deep DiveCellular Reprogramming
The Evidence Pack: How Partial Cellular Reprogramming is Entering Human Trials to Reverse Vision Loss
Longevity Researchers 40%Clinical Ophthalmologists 35%Safety & Bioethics Monitors 25%
5 sources · 29d ago
Factlen Deep DiveCellular Aging
The Evidence Pack: How GlyNAC Supplementation Reverses Multiple Hallmarks of Biological Aging
Longevity Researchers 40%Clinical Skeptics 30%Geriatric Medicine Specialists 30%
5 sources · 29d ago
Factlen Deep DiveCellular Aging
The Evidence Pack: How Urolithin A and Mitophagy Are Rewriting Cellular Aging
Longevity Researchers 41%Clinical Gerontologists 35%Nutritional Scientists 24%
7 sources · 29d ago
Factlen Deep DiveTaurine Science
The Evidence Pack: Does Taurine Actually Slow the Aging Process?
Geroscience Researchers 45%Clinical Skeptics 35%Metabolic Specialists 20%
4 sources · 29d ago